Holen Sie sich die Stockscreener-App
340.41
1.20%
4.02
Handel nachbörslich:
340.41
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
West Pharmaceutical Services Inc (WST)'s Winning Formula: Financ - GuruFocus
West Pharmaceutical Services stock hits 52-week high at $338.73 - Investing.com
West Pharmaceutical Services stock hits 52-week high at $338.73 By Investing.com - Investing.com Canada
Is West Pharmaceutical stock outperforming the S&P 500? - MSN
West Pharmaceutical Services Inc (WST) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
West Pharmaceutical Services, Inc. (WST) hit a 52 week high, can the run continue? - MSN
The SmartDose 10 mL system from West Pharmaceutical Services Inc.large-volume self-injection with - Ad-hoc-news.de
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
West Pharmaceutical opens the week with clear analyst consensus, shares hold near recent highs - Ad-hoc-news.de
Revvity Launches Signals AI to Advance Scientific R&D Workflows - TradingView
West Pharmaceutical Services names Michel Lagarde as next CEO, effective Aug. 31 - MSN
The NovaPure Plunger from West Pharmaceuticaltight particle specs for sensitive biologics - AD HOC NEWS
West Pharmaceutical StockSunday background on valuation and growth drivers - AD HOC NEWS
West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth Narrative - Yahoo Finance
Why West Pharmaceutical’s NovaGuard SA Pro quietly matters for everyday injections - AD HOC NEWS
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026? - TradingView
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell? - TradingView
West Pharmaceutical Services Inc (WST) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cencora Launches Enhanced Nucleus Solution for Specialty Practices - TradingView
West Pharmaceutical stock under pressure after weekly high as technicals suggest range trading ahead - Traders Union
West Pharmaceutical Services Inc - TradingKey
West Pharmaceutical Services Inc (WST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
West Pharmaceutical Services Inc (WST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
West Pharmaceutical stock slips to weekly low amid conflicting momentum signals - Traders Union
Why West Pharmaceutical’s NovaPure plungers quietly matter for injectable drugs - AD HOC NEWS
West Pharmaceutical Services Inc (WST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
West Pharmaceutical Services Inc (WST) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
West Pharmaceutical Services Inc (WST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
West Pharmaceutical Services Inc (WST) Institutional Confidence - TradingKey
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West Pharmaceutical Services Strengthens Support for China’s Biologics Ecosystem with Integrated Prefillable Syringe System Launch at CPHI China 2026 - 巴士的報
Aluminum Crimp Vial Seals Market Forecast to 2035: Growth Accelerates on Biologic Drug Surge and RTU Adoption - IndexBox
Reasons to Retain Baxter International Stock in Your Portfolio for Now - TradingView
West pharmaceutical services strengthens support for china’s biologics ecosystem with integrated prefillable syringe system launch at CPHI China 2026 - The Sun Malaysia
West Pharmaceutical Services Strengthens Support for China’s Biologics Ecosystem with Integrated Prefillable Syringe System Launch at CPHI China 2026 #WestPharmaceuticalServices - Media OutReach Newswire
New release highlights: Westar Select Ready Pack vials target small-batch biologics - AD HOC NEWS
New price band, same precision: West’s Stelmi Ready Pack seeks broader biologics use - AD HOC NEWS
How Investors May Respond To West Pharmaceutical Services (WST) Upgraded 2026 Outlook And Biologics Momentum - Yahoo Finance
Is West Pharmaceutical Stock Outperforming the S&P 500? - Barchart.com
West Pharmaceutical Stock (US9523901012): Quiet trading day keeps valuation in focus - AD HOC NEWS
West Pharmaceutical Services (WST) Stock Valuation Check After Recent Momentum And Premium P/E Ratio - Sahm
West Pharmaceutical Services (WST) Is an Injectable-Drug Infrastructure Story, Not Just a Packaging Supplier - AlphaStreet
Is Wall Street bullish or bearish on West Pharmaceutical Services stock? - MSN
West Pharmaceutical Stock (US9553061055): Valuation Metrics Under the Microscope on a Quiet Friday - AD HOC NEWS
West Pharmaceutical Stock (US9523901012): Valuation Metrics Under the Microscope - AD HOC NEWS
West Pharma’s GLP-1 Tailwinds Come With A Cybersecurity Footnote - Finimize
West NovaGuard® SA Pro Safety System Recognized for Excellence in Design and User Experience at the India Packaging Awards - Devdiscourse
Reasons to Add Veeva Systems Stock to Your Portfolio for Now - TradingView
West Pharmaceutical Names Thermo Fisher Executive as CEO - MyChesCo
AMN Expands Language Services Portfolio With Jaide Health Deal - TradingView
Motley Fool Wealth Management LLC Reduces Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
Here's what to expect from West Pharmaceutical's next earnings report - MSN
West Pharma raised to overweight at Barclays on fundamentals - MSN
2.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):